基础医学与临床 ›› 2014, Vol. 34 ›› Issue (10): 1446-1449.

• 短篇综述 • 上一篇    下一篇

人趋化因子受体1及其与某些疾病的关系

覃彦平   

  1. 柳州市红十字会医院
  • 收稿日期:2013-11-25 修回日期:2014-03-25 出版日期:2014-10-05 发布日期:2014-09-25
  • 通讯作者: 覃彦平 E-mail:1227143070@qq.com

Human Chemokine receptor-like 1 and the relation with disease

  • Received:2013-11-25 Revised:2014-03-25 Online:2014-10-05 Published:2014-09-25

摘要: 人趋化因子受体1(CMKLR1 / ChemR23)是趋化脂肪因子Chemerin及ω-3脂肪酸衍生分子resolvin E1的共享性受体。CMKLR1与其特异性配体结合后能刺激细胞内Ca2+释放,激活ERK1和NF-κB等信号级联反应,与炎症、免疫性疾病、糖尿病、代谢性疾病、心血管系统疾病、骨病、肿瘤、生殖系统疾病、精神疾病和肝脏等疾病发病相关。

Abstract: Chemokine receptor-like 1 is sharing receptor of Chemerin and resolvin E1. After chemokine receptors 1 and its specific ligand had binded, intracellular calcium were stimulated to release, NF-κB、ERK1 and other signalings cascade activation reaction were leaded, it has been shown to be associated with inflammation, autoimmune disease, diabetes, metabolic diseases, cardiovascular diseases, bone diseases, tumors, reproductive system diseases, mental diseases and pathogenesis of liver diseases.